MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Nasal inflammation, nasal polyps and rhinitis

  August 2017: Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration.

 December 2014: Inhaled and intranasal corticosteroids.

 December 2014: Corticosteroids: early psychiatric side-effects

Important safety information

The CSM recommends that when children are receiving prolonged treatment with nasal corticosteroids the height of the child should be monitored. If growth is slowed than paediatric referral should be considered. They are not licensed for use in young children.

Beclometasone nasal spray, available as a generic, is considered as first line therapy. It is relatively cheap, effective and well tolerated, requiring twice daily administration.

Beclometasone is licensed for the prophylaxis and treatment of allergic and vasomator rhinitis. Fluticasone is only licensed for the prophylaxis and treatment of allergic rhinitis.

Fluticasone furoate has a novel device which some adults and children may find easier to use.

Betamethasone nose drops are licensed for non-infected inflammatory conditions of the ear or nose.

For seasonal rhinitis, prophylaxis should begin one week before the start of the pollen season and continue throughout.

Systemic absorption may follow on from any nasal steroid particularly if the doses are high and prolonged.

Some brands are available over the counter eg Pirinase Hayfever

Pack Price
150 dose £11.01
Pack Price
120 dose £6.44

Nasal polyps only

Pack Price
28 unit dose (4 x 7 unit doses) £12.99

Some brands are available over the counter

Pack Price
140 dose £1.60